nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP2C8—Trimethadione—epilepsy syndrome	0.047	0.0784	CbGbCtD
Bezafibrate—CYP1A1—Propofol—epilepsy syndrome	0.046	0.0768	CbGbCtD
Bezafibrate—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0442	0.0737	CbGbCtD
Bezafibrate—CYP1A1—Phenobarbital—epilepsy syndrome	0.044	0.0734	CbGbCtD
Bezafibrate—CYP2C8—Carbamazepine—epilepsy syndrome	0.0317	0.053	CbGbCtD
Bezafibrate—CYP2C8—Primidone—epilepsy syndrome	0.0296	0.0494	CbGbCtD
Bezafibrate—CYP2C8—Phenytoin—epilepsy syndrome	0.0285	0.0475	CbGbCtD
Bezafibrate—CYP2C8—Propofol—epilepsy syndrome	0.0265	0.0443	CbGbCtD
Bezafibrate—CYP2C8—Phenobarbital—epilepsy syndrome	0.0254	0.0423	CbGbCtD
Bezafibrate—CYP2C8—Diazepam—epilepsy syndrome	0.024	0.0401	CbGbCtD
Bezafibrate—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0205	0.0342	CbGbCtD
Bezafibrate—CYP3A4—Felbamate—epilepsy syndrome	0.0191	0.0318	CbGbCtD
Bezafibrate—CYP3A4—Trimethadione—epilepsy syndrome	0.0191	0.0318	CbGbCtD
Bezafibrate—CYP2C8—Valproic Acid—epilepsy syndrome	0.019	0.0316	CbGbCtD
Bezafibrate—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0179	0.0299	CbGbCtD
Bezafibrate—CYP3A4—Clonazepam—epilepsy syndrome	0.0162	0.027	CbGbCtD
Bezafibrate—CYP3A4—Clobazam—epilepsy syndrome	0.0155	0.0259	CbGbCtD
Bezafibrate—CYP3A4—Rufinamide—epilepsy syndrome	0.0132	0.022	CbGbCtD
Bezafibrate—CYP3A4—Carbamazepine—epilepsy syndrome	0.0129	0.0215	CbGbCtD
Bezafibrate—CYP3A4—Primidone—epilepsy syndrome	0.012	0.02	CbGbCtD
Bezafibrate—CYP3A4—Phenytoin—epilepsy syndrome	0.0115	0.0193	CbGbCtD
Bezafibrate—CYP3A4—Propofol—epilepsy syndrome	0.0108	0.018	CbGbCtD
Bezafibrate—CYP3A4—Phenobarbital—epilepsy syndrome	0.0103	0.0172	CbGbCtD
Bezafibrate—CYP3A4—Acetazolamide—epilepsy syndrome	0.0103	0.0172	CbGbCtD
Bezafibrate—CYP3A4—Midazolam—epilepsy syndrome	0.0101	0.0169	CbGbCtD
Bezafibrate—CYP3A4—Diazepam—epilepsy syndrome	0.00975	0.0163	CbGbCtD
Bezafibrate—CYP3A4—Zonisamide—epilepsy syndrome	0.00952	0.0159	CbGbCtD
Bezafibrate—CYP3A4—Valproic Acid—epilepsy syndrome	0.00769	0.0128	CbGbCtD
Bezafibrate—CYP3A4—Topiramate—epilepsy syndrome	0.00694	0.0116	CbGbCtD
Bezafibrate—PPARG—forelimb—epilepsy syndrome	0.0044	0.134	CbGeAlD
Bezafibrate—Progabide—GABBR1—epilepsy syndrome	0.00393	0.472	CrCbGaD
Bezafibrate—PPARD—forebrain—epilepsy syndrome	0.00213	0.0647	CbGeAlD
Bezafibrate—PPARD—telencephalon—epilepsy syndrome	0.00196	0.0595	CbGeAlD
Bezafibrate—PPARD—midbrain—epilepsy syndrome	0.00141	0.0427	CbGeAlD
Bezafibrate—Progabide—GABRA1—epilepsy syndrome	0.00137	0.164	CrCbGaD
Bezafibrate—PPARD—head—epilepsy syndrome	0.00122	0.0371	CbGeAlD
Bezafibrate—HMGCR—forebrain—epilepsy syndrome	0.00121	0.0367	CbGeAlD
Bezafibrate—PPARD—nervous system—epilepsy syndrome	0.00116	0.0351	CbGeAlD
Bezafibrate—PPARD—central nervous system—epilepsy syndrome	0.00111	0.0338	CbGeAlD
Bezafibrate—HMGCR—telencephalon—epilepsy syndrome	0.00111	0.0337	CbGeAlD
Bezafibrate—PPARD—cerebellum—epilepsy syndrome	0.00109	0.0331	CbGeAlD
Bezafibrate—PPARA—head—epilepsy syndrome	0.00104	0.0316	CbGeAlD
Bezafibrate—PPARG—forebrain—epilepsy syndrome	0.000998	0.0303	CbGeAlD
Bezafibrate—PPARA—nervous system—epilepsy syndrome	0.000985	0.0299	CbGeAlD
Bezafibrate—PPARA—central nervous system—epilepsy syndrome	0.000948	0.0288	CbGeAlD
Bezafibrate—PPARA—cerebellum—epilepsy syndrome	0.000927	0.0282	CbGeAlD
Bezafibrate—PPARD—brain—epilepsy syndrome	0.000883	0.0269	CbGeAlD
Bezafibrate—HMGCR—medulla oblongata—epilepsy syndrome	0.000872	0.0265	CbGeAlD
Bezafibrate—HMGCR—midbrain—epilepsy syndrome	0.000797	0.0242	CbGeAlD
Bezafibrate—HMGCR—spinal cord—epilepsy syndrome	0.000778	0.0236	CbGeAlD
Bezafibrate—PPARA—brain—epilepsy syndrome	0.000753	0.0229	CbGeAlD
Bezafibrate—HMGCR—head—epilepsy syndrome	0.000691	0.021	CbGeAlD
Bezafibrate—HMGCR—nervous system—epilepsy syndrome	0.000655	0.0199	CbGeAlD
Bezafibrate—HMGCR—central nervous system—epilepsy syndrome	0.000631	0.0192	CbGeAlD
Bezafibrate—HMGCR—cerebellum—epilepsy syndrome	0.000617	0.0187	CbGeAlD
Bezafibrate—PPARG—head—epilepsy syndrome	0.000571	0.0174	CbGeAlD
Bezafibrate—PPARG—nervous system—epilepsy syndrome	0.000542	0.0165	CbGeAlD
Bezafibrate—PPARG—central nervous system—epilepsy syndrome	0.000521	0.0158	CbGeAlD
Bezafibrate—HMGCR—brain—epilepsy syndrome	0.000501	0.0152	CbGeAlD
Bezafibrate—PPARG—brain—epilepsy syndrome	0.000414	0.0126	CbGeAlD
Bezafibrate—CYP1A1—head—epilepsy syndrome	0.000348	0.0106	CbGeAlD
Bezafibrate—Aminohippurate—SLCO1A2—epilepsy syndrome	0.000344	0.0413	CrCbGaD
Bezafibrate—CYP1A1—nervous system—epilepsy syndrome	0.00033	0.01	CbGeAlD
Bezafibrate—CYP1A1—central nervous system—epilepsy syndrome	0.000317	0.00964	CbGeAlD
Bezafibrate—Indomethacin—SLCO1A2—epilepsy syndrome	0.000315	0.0379	CrCbGaD
Bezafibrate—Glyburide—SLCO1A2—epilepsy syndrome	0.000285	0.0342	CrCbGaD
Bezafibrate—CYP2C8—brain—epilepsy syndrome	0.000273	0.00829	CbGeAlD
Bezafibrate—CYP1A1—brain—epilepsy syndrome	0.000252	0.00766	CbGeAlD
Bezafibrate—Glyburide—KCNJ11—epilepsy syndrome	0.000252	0.0303	CrCbGaD
Bezafibrate—CYP3A4—nervous system—epilepsy syndrome	0.000242	0.00735	CbGeAlD
Bezafibrate—CYP3A4—central nervous system—epilepsy syndrome	0.000233	0.00708	CbGeAlD
Bezafibrate—Hypersensitivity—Midazolam—epilepsy syndrome	0.000221	0.000979	CcSEcCtD
Bezafibrate—Dyspepsia—Clonazepam—epilepsy syndrome	0.000221	0.000976	CcSEcCtD
Bezafibrate—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000221	0.000976	CcSEcCtD
Bezafibrate—Flatulence—Valproic Acid—epilepsy syndrome	0.000221	0.000975	CcSEcCtD
Bezafibrate—Nausea—Clobazam—epilepsy syndrome	0.00022	0.000974	CcSEcCtD
Bezafibrate—Erythema multiforme—Pregabalin—epilepsy syndrome	0.00022	0.000972	CcSEcCtD
Bezafibrate—Dyspepsia—Phenytoin—epilepsy syndrome	0.000219	0.00097	CcSEcCtD
Bezafibrate—Dizziness—Acetazolamide—epilepsy syndrome	0.000219	0.000967	CcSEcCtD
Bezafibrate—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000219	0.000966	CcSEcCtD
Bezafibrate—Urticaria—Diazepam—epilepsy syndrome	0.000218	0.000965	CcSEcCtD
Bezafibrate—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000218	0.000965	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000217	0.000962	CcSEcCtD
Bezafibrate—Moclobemide—CYP2C19—epilepsy syndrome	0.000217	0.0261	CrCbGaD
Bezafibrate—Pruritus—Propofol—epilepsy syndrome	0.000217	0.000961	CcSEcCtD
Bezafibrate—Abdominal pain—Diazepam—epilepsy syndrome	0.000217	0.00096	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000217	0.000958	CcSEcCtD
Bezafibrate—Bronchitis—Topiramate—epilepsy syndrome	0.000215	0.000953	CcSEcCtD
Bezafibrate—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000215	0.000952	CcSEcCtD
Bezafibrate—Insomnia—Carbamazepine—epilepsy syndrome	0.000215	0.000951	CcSEcCtD
Bezafibrate—Pain—Clonazepam—epilepsy syndrome	0.000215	0.000949	CcSEcCtD
Bezafibrate—Constipation—Clonazepam—epilepsy syndrome	0.000215	0.000949	CcSEcCtD
Bezafibrate—Constipation—Phenytoin—epilepsy syndrome	0.000213	0.000942	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000213	0.000941	CcSEcCtD
Bezafibrate—Pancytopenia—Topiramate—epilepsy syndrome	0.000213	0.000941	CcSEcCtD
Bezafibrate—Pruritus—Midazolam—epilepsy syndrome	0.000213	0.00094	CcSEcCtD
Bezafibrate—Pain—Oxcarbazepine—epilepsy syndrome	0.000212	0.000937	CcSEcCtD
Bezafibrate—Constipation—Oxcarbazepine—epilepsy syndrome	0.000212	0.000937	CcSEcCtD
Bezafibrate—Pharyngitis—Gabapentin—epilepsy syndrome	0.000212	0.000935	CcSEcCtD
Bezafibrate—Urticaria—Felbamate—epilepsy syndrome	0.000211	0.000934	CcSEcCtD
Bezafibrate—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000211	0.000931	CcSEcCtD
Bezafibrate—Abdominal pain—Felbamate—epilepsy syndrome	0.00021	0.00093	CcSEcCtD
Bezafibrate—Diarrhoea—Propofol—epilepsy syndrome	0.00021	0.000929	CcSEcCtD
Bezafibrate—Pruritus—Levetiracetam—epilepsy syndrome	0.00021	0.000928	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000209	0.000926	CcSEcCtD
Bezafibrate—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000209	0.000926	CcSEcCtD
Bezafibrate—Urethral disorder—Gabapentin—epilepsy syndrome	0.000209	0.000924	CcSEcCtD
Bezafibrate—Insomnia—Lamotrigine—epilepsy syndrome	0.000208	0.000919	CcSEcCtD
Bezafibrate—Headache—Acetazolamide—epilepsy syndrome	0.000207	0.000916	CcSEcCtD
Bezafibrate—Anaemia—Valproic Acid—epilepsy syndrome	0.000207	0.000915	CcSEcCtD
Bezafibrate—Urticaria—Zonisamide—epilepsy syndrome	0.000207	0.000914	CcSEcCtD
Bezafibrate—Erectile dysfunction—Topiramate—epilepsy syndrome	0.000206	0.000912	CcSEcCtD
Bezafibrate—Abdominal pain—Zonisamide—epilepsy syndrome	0.000206	0.00091	CcSEcCtD
Bezafibrate—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000206	0.000909	CcSEcCtD
Bezafibrate—Alopecia—Pregabalin—epilepsy syndrome	0.000205	0.000908	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000205	0.000907	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Topiramate—epilepsy syndrome	0.000205	0.000904	CcSEcCtD
Bezafibrate—Constipation—Carbamazepine—epilepsy syndrome	0.000203	0.000899	CcSEcCtD
Bezafibrate—Pain—Carbamazepine—epilepsy syndrome	0.000203	0.000899	CcSEcCtD
Bezafibrate—Dizziness—Propofol—epilepsy syndrome	0.000203	0.000898	CcSEcCtD
Bezafibrate—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000203	0.000898	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000203	0.000896	CcSEcCtD
Bezafibrate—Pruritus—Fosphenytoin—epilepsy syndrome	0.000203	0.000896	CcSEcCtD
Bezafibrate—Hypersensitivity—Diazepam—epilepsy syndrome	0.000202	0.000895	CcSEcCtD
Bezafibrate—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000202	0.000895	CcSEcCtD
Bezafibrate—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000202	0.000891	CcSEcCtD
Bezafibrate—Flatulence—Pregabalin—epilepsy syndrome	0.000199	0.000882	CcSEcCtD
Bezafibrate—Urticaria—Clonazepam—epilepsy syndrome	0.000199	0.000881	CcSEcCtD
Bezafibrate—Dizziness—Midazolam—epilepsy syndrome	0.000199	0.000878	CcSEcCtD
Bezafibrate—Abdominal pain—Clonazepam—epilepsy syndrome	0.000198	0.000877	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000198	0.000876	CcSEcCtD
Bezafibrate—Urticaria—Phenytoin—epilepsy syndrome	0.000198	0.000875	CcSEcCtD
Bezafibrate—Pruritus—Vigabatrin—epilepsy syndrome	0.000197	0.000873	CcSEcCtD
Bezafibrate—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000197	0.000871	CcSEcCtD
Bezafibrate—Constipation—Lamotrigine—epilepsy syndrome	0.000197	0.000869	CcSEcCtD
Bezafibrate—Pain—Lamotrigine—epilepsy syndrome	0.000197	0.000869	CcSEcCtD
Bezafibrate—Nausea—Acetazolamide—epilepsy syndrome	0.000196	0.000868	CcSEcCtD
Bezafibrate—Dizziness—Levetiracetam—epilepsy syndrome	0.000196	0.000867	CcSEcCtD
Bezafibrate—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000196	0.000866	CcSEcCtD
Bezafibrate—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000196	0.000866	CcSEcCtD
Bezafibrate—Muscle spasms—Pregabalin—epilepsy syndrome	0.000195	0.00086	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000195	0.00086	CcSEcCtD
Bezafibrate—Pruritus—Diazepam—epilepsy syndrome	0.000194	0.00086	CcSEcCtD
Bezafibrate—Rash—Propofol—epilepsy syndrome	0.000194	0.000856	CcSEcCtD
Bezafibrate—Dermatitis—Propofol—epilepsy syndrome	0.000193	0.000855	CcSEcCtD
Bezafibrate—Headache—Propofol—epilepsy syndrome	0.000192	0.000851	CcSEcCtD
Bezafibrate—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000192	0.000848	CcSEcCtD
Bezafibrate—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000191	0.000844	CcSEcCtD
Bezafibrate—Myalgia—Valproic Acid—epilepsy syndrome	0.000191	0.000843	CcSEcCtD
Bezafibrate—Encainide—CYP2D6—epilepsy syndrome	0.00019	0.0228	CrCbGaD
Bezafibrate—Rash—Midazolam—epilepsy syndrome	0.000189	0.000838	CcSEcCtD
Bezafibrate—Dizziness—Fosphenytoin—epilepsy syndrome	0.000189	0.000837	CcSEcCtD
Bezafibrate—Dermatitis—Midazolam—epilepsy syndrome	0.000189	0.000837	CcSEcCtD
Bezafibrate—Urticaria—Carbamazepine—epilepsy syndrome	0.000189	0.000836	CcSEcCtD
Bezafibrate—Alopecia—Gabapentin—epilepsy syndrome	0.000188	0.000833	CcSEcCtD
Bezafibrate—Headache—Midazolam—epilepsy syndrome	0.000188	0.000832	CcSEcCtD
Bezafibrate—Pruritus—Felbamate—epilepsy syndrome	0.000188	0.000832	CcSEcCtD
Bezafibrate—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000188	0.000831	CcSEcCtD
Bezafibrate—Diarrhoea—Diazepam—epilepsy syndrome	0.000188	0.000831	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000188	0.000831	CcSEcCtD
Bezafibrate—Rash—Levetiracetam—epilepsy syndrome	0.000187	0.000827	CcSEcCtD
Bezafibrate—Anaemia—Pregabalin—epilepsy syndrome	0.000187	0.000827	CcSEcCtD
Bezafibrate—Dermatitis—Levetiracetam—epilepsy syndrome	0.000187	0.000826	CcSEcCtD
Bezafibrate—Headache—Levetiracetam—epilepsy syndrome	0.000186	0.000822	CcSEcCtD
Bezafibrate—Erythema—Gabapentin—epilepsy syndrome	0.000186	0.00082	CcSEcCtD
Bezafibrate—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000185	0.000817	CcSEcCtD
Bezafibrate—Dizziness—Vigabatrin—epilepsy syndrome	0.000185	0.000816	CcSEcCtD
Bezafibrate—Pruritus—Zonisamide—epilepsy syndrome	0.000184	0.000814	CcSEcCtD
Bezafibrate—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000184	0.000812	CcSEcCtD
Bezafibrate—Flatulence—Gabapentin—epilepsy syndrome	0.000183	0.000808	CcSEcCtD
Bezafibrate—Urticaria—Lamotrigine—epilepsy syndrome	0.000183	0.000808	CcSEcCtD
Bezafibrate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000183	0.000808	CcSEcCtD
Bezafibrate—Nausea—Propofol—epilepsy syndrome	0.000182	0.000806	CcSEcCtD
Bezafibrate—Diarrhoea—Felbamate—epilepsy syndrome	0.000182	0.000805	CcSEcCtD
Bezafibrate—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000182	0.000804	CcSEcCtD
Bezafibrate—Dizziness—Diazepam—epilepsy syndrome	0.000182	0.000803	CcSEcCtD
Bezafibrate—Infection—Valproic Acid—epilepsy syndrome	0.000181	0.000802	CcSEcCtD
Bezafibrate—Rash—Fosphenytoin—epilepsy syndrome	0.000181	0.000798	CcSEcCtD
Bezafibrate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00018	0.000798	CcSEcCtD
Bezafibrate—Headache—Fosphenytoin—epilepsy syndrome	0.000179	0.000793	CcSEcCtD
Bezafibrate—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000179	0.000791	CcSEcCtD
Bezafibrate—Nausea—Midazolam—epilepsy syndrome	0.000178	0.000789	CcSEcCtD
Bezafibrate—Muscle spasms—Gabapentin—epilepsy syndrome	0.000178	0.000789	CcSEcCtD
Bezafibrate—Diarrhoea—Zonisamide—epilepsy syndrome	0.000178	0.000788	CcSEcCtD
Bezafibrate—Pharyngitis—Topiramate—epilepsy syndrome	0.000178	0.000787	CcSEcCtD
Bezafibrate—Pruritus—Clonazepam—epilepsy syndrome	0.000178	0.000785	CcSEcCtD
Bezafibrate—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000177	0.000783	CcSEcCtD
Bezafibrate—Pruritus—Phenytoin—epilepsy syndrome	0.000176	0.00078	CcSEcCtD
Bezafibrate—Nausea—Levetiracetam—epilepsy syndrome	0.000176	0.000779	CcSEcCtD
Bezafibrate—Rash—Vigabatrin—epilepsy syndrome	0.000176	0.000778	CcSEcCtD
Bezafibrate—Dizziness—Felbamate—epilepsy syndrome	0.000176	0.000778	CcSEcCtD
Bezafibrate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000176	0.000777	CcSEcCtD
Bezafibrate—Urethral disorder—Topiramate—epilepsy syndrome	0.000176	0.000777	CcSEcCtD
Bezafibrate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000175	0.000775	CcSEcCtD
Bezafibrate—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000175	0.000775	CcSEcCtD
Bezafibrate—Headache—Vigabatrin—epilepsy syndrome	0.000175	0.000773	CcSEcCtD
Bezafibrate—Rash—Diazepam—epilepsy syndrome	0.000173	0.000766	CcSEcCtD
Bezafibrate—Dermatitis—Diazepam—epilepsy syndrome	0.000173	0.000765	CcSEcCtD
Bezafibrate—Myalgia—Pregabalin—epilepsy syndrome	0.000172	0.000762	CcSEcCtD
Bezafibrate—Dizziness—Zonisamide—epilepsy syndrome	0.000172	0.000761	CcSEcCtD
Bezafibrate—Headache—Diazepam—epilepsy syndrome	0.000172	0.000761	CcSEcCtD
Bezafibrate—Diarrhoea—Clonazepam—epilepsy syndrome	0.000172	0.000759	CcSEcCtD
Bezafibrate—Anaemia—Gabapentin—epilepsy syndrome	0.000172	0.000758	CcSEcCtD
Bezafibrate—Diarrhoea—Phenytoin—epilepsy syndrome	0.000171	0.000754	CcSEcCtD
Bezafibrate—Nausea—Fosphenytoin—epilepsy syndrome	0.00017	0.000752	CcSEcCtD
Bezafibrate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00017	0.00075	CcSEcCtD
Bezafibrate—Erythema multiforme—Topiramate—epilepsy syndrome	0.00017	0.00075	CcSEcCtD
Bezafibrate—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000169	0.000749	CcSEcCtD
Bezafibrate—Pruritus—Carbamazepine—epilepsy syndrome	0.000168	0.000744	CcSEcCtD
Bezafibrate—Rash—Felbamate—epilepsy syndrome	0.000168	0.000741	CcSEcCtD
Bezafibrate—Dermatitis—Felbamate—epilepsy syndrome	0.000168	0.000741	CcSEcCtD
Bezafibrate—Headache—Felbamate—epilepsy syndrome	0.000167	0.000737	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000166	0.000736	CcSEcCtD
Bezafibrate—Dizziness—Clonazepam—epilepsy syndrome	0.000166	0.000734	CcSEcCtD
Bezafibrate—Nausea—Vigabatrin—epilepsy syndrome	0.000166	0.000733	CcSEcCtD
Bezafibrate—Insomnia—Valproic Acid—epilepsy syndrome	0.000165	0.000731	CcSEcCtD
Bezafibrate—Dizziness—Phenytoin—epilepsy syndrome	0.000165	0.000729	CcSEcCtD
Bezafibrate—Aminohippurate—ABCC2—epilepsy syndrome	0.000164	0.0198	CrCbGaD
Bezafibrate—Rash—Zonisamide—epilepsy syndrome	0.000164	0.000726	CcSEcCtD
Bezafibrate—Infection—Pregabalin—epilepsy syndrome	0.000164	0.000725	CcSEcCtD
Bezafibrate—Dermatitis—Zonisamide—epilepsy syndrome	0.000164	0.000725	CcSEcCtD
Bezafibrate—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000164	0.000725	CcSEcCtD
Bezafibrate—Nausea—Diazepam—epilepsy syndrome	0.000163	0.000722	CcSEcCtD
Bezafibrate—Headache—Zonisamide—epilepsy syndrome	0.000163	0.000721	CcSEcCtD
Bezafibrate—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000163	0.00072	CcSEcCtD
Bezafibrate—Pruritus—Lamotrigine—epilepsy syndrome	0.000163	0.000719	CcSEcCtD
Bezafibrate—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000162	0.000715	CcSEcCtD
Bezafibrate—Moclobemide—CYP2D6—epilepsy syndrome	0.000161	0.0194	CrCbGaD
Bezafibrate—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000161	0.000711	CcSEcCtD
Bezafibrate—Alopecia—Topiramate—epilepsy syndrome	0.000158	0.000701	CcSEcCtD
Bezafibrate—Rash—Clonazepam—epilepsy syndrome	0.000158	0.000699	CcSEcCtD
Bezafibrate—Dermatitis—Clonazepam—epilepsy syndrome	0.000158	0.000699	CcSEcCtD
Bezafibrate—Myalgia—Gabapentin—epilepsy syndrome	0.000158	0.000699	CcSEcCtD
Bezafibrate—Nausea—Felbamate—epilepsy syndrome	0.000158	0.000698	CcSEcCtD
Bezafibrate—Dizziness—Carbamazepine—epilepsy syndrome	0.000157	0.000696	CcSEcCtD
Bezafibrate—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000157	0.000696	CcSEcCtD
Bezafibrate—Headache—Clonazepam—epilepsy syndrome	0.000157	0.000695	CcSEcCtD
Bezafibrate—Rash—Phenytoin—epilepsy syndrome	0.000157	0.000695	CcSEcCtD
Bezafibrate—Dermatitis—Phenytoin—epilepsy syndrome	0.000157	0.000694	CcSEcCtD
Bezafibrate—Rash—Oxcarbazepine—epilepsy syndrome	0.000156	0.000691	CcSEcCtD
Bezafibrate—Constipation—Valproic Acid—epilepsy syndrome	0.000156	0.000691	CcSEcCtD
Bezafibrate—Pain—Valproic Acid—epilepsy syndrome	0.000156	0.000691	CcSEcCtD
Bezafibrate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000156	0.00069	CcSEcCtD
Bezafibrate—Headache—Phenytoin—epilepsy syndrome	0.000156	0.00069	CcSEcCtD
Bezafibrate—Erythema—Topiramate—epilepsy syndrome	0.000156	0.00069	CcSEcCtD
Bezafibrate—Headache—Oxcarbazepine—epilepsy syndrome	0.000155	0.000687	CcSEcCtD
Bezafibrate—Nausea—Zonisamide—epilepsy syndrome	0.000155	0.000684	CcSEcCtD
Bezafibrate—Flatulence—Topiramate—epilepsy syndrome	0.000154	0.00068	CcSEcCtD
Bezafibrate—Dizziness—Lamotrigine—epilepsy syndrome	0.000152	0.000672	CcSEcCtD
Bezafibrate—Indomethacin—ABCC2—epilepsy syndrome	0.000151	0.0181	CrCbGaD
Bezafibrate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.00015	0.000665	CcSEcCtD
Bezafibrate—Infection—Gabapentin—epilepsy syndrome	0.00015	0.000665	CcSEcCtD
Bezafibrate—Muscle spasms—Topiramate—epilepsy syndrome	0.00015	0.000664	CcSEcCtD
Bezafibrate—Rash—Carbamazepine—epilepsy syndrome	0.00015	0.000663	CcSEcCtD
Bezafibrate—Dermatitis—Carbamazepine—epilepsy syndrome	0.00015	0.000663	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000149	0.000661	CcSEcCtD
Bezafibrate—Insomnia—Pregabalin—epilepsy syndrome	0.000149	0.00066	CcSEcCtD
Bezafibrate—Nausea—Clonazepam—epilepsy syndrome	0.000149	0.000659	CcSEcCtD
Bezafibrate—Headache—Carbamazepine—epilepsy syndrome	0.000149	0.000659	CcSEcCtD
Bezafibrate—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000148	0.000656	CcSEcCtD
Bezafibrate—Nausea—Phenytoin—epilepsy syndrome	0.000148	0.000654	CcSEcCtD
Bezafibrate—Balsalazide—PTGS2—epilepsy syndrome	0.000148	0.0178	CrCbGaD
Bezafibrate—Nausea—Oxcarbazepine—epilepsy syndrome	0.000147	0.000651	CcSEcCtD
Bezafibrate—Urticaria—Valproic Acid—epilepsy syndrome	0.000145	0.000642	CcSEcCtD
Bezafibrate—Rash—Lamotrigine—epilepsy syndrome	0.000145	0.000641	CcSEcCtD
Bezafibrate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000145	0.00064	CcSEcCtD
Bezafibrate—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000144	0.000639	CcSEcCtD
Bezafibrate—Anaemia—Topiramate—epilepsy syndrome	0.000144	0.000638	CcSEcCtD
Bezafibrate—Headache—Lamotrigine—epilepsy syndrome	0.000144	0.000637	CcSEcCtD
Bezafibrate—Nausea—Carbamazepine—epilepsy syndrome	0.000141	0.000625	CcSEcCtD
Bezafibrate—Pain—Pregabalin—epilepsy syndrome	0.000141	0.000624	CcSEcCtD
Bezafibrate—Constipation—Pregabalin—epilepsy syndrome	0.000141	0.000624	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000138	0.00061	CcSEcCtD
Bezafibrate—Insomnia—Gabapentin—epilepsy syndrome	0.000137	0.000606	CcSEcCtD
Bezafibrate—Nausea—Lamotrigine—epilepsy syndrome	0.000137	0.000604	CcSEcCtD
Bezafibrate—Glyburide—ABCC2—epilepsy syndrome	0.000136	0.0164	CrCbGaD
Bezafibrate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000135	0.000597	CcSEcCtD
Bezafibrate—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000135	0.000595	CcSEcCtD
Bezafibrate—Dyspepsia—Gabapentin—epilepsy syndrome	0.000133	0.000589	CcSEcCtD
Bezafibrate—Myalgia—Topiramate—epilepsy syndrome	0.000133	0.000588	CcSEcCtD
Bezafibrate—Urticaria—Pregabalin—epilepsy syndrome	0.000131	0.00058	CcSEcCtD
Bezafibrate—Abdominal pain—Pregabalin—epilepsy syndrome	0.000131	0.000577	CcSEcCtD
Bezafibrate—Pain—Gabapentin—epilepsy syndrome	0.00013	0.000573	CcSEcCtD
Bezafibrate—Constipation—Gabapentin—epilepsy syndrome	0.00013	0.000573	CcSEcCtD
Bezafibrate—Pruritus—Valproic Acid—epilepsy syndrome	0.000129	0.000571	CcSEcCtD
Bezafibrate—Infection—Topiramate—epilepsy syndrome	0.000127	0.00056	CcSEcCtD
Bezafibrate—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000125	0.000553	CcSEcCtD
Bezafibrate—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000125	0.000552	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000124	0.000548	CcSEcCtD
Bezafibrate—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000122	0.000538	CcSEcCtD
Bezafibrate—Dizziness—Valproic Acid—epilepsy syndrome	0.000121	0.000534	CcSEcCtD
Bezafibrate—Glyburide—ABCG2—epilepsy syndrome	0.00012	0.0145	CrCbGaD
Bezafibrate—Urticaria—Gabapentin—epilepsy syndrome	0.00012	0.000532	CcSEcCtD
Bezafibrate—Abdominal pain—Gabapentin—epilepsy syndrome	0.00012	0.000529	CcSEcCtD
Bezafibrate—Pruritus—Pregabalin—epilepsy syndrome	0.000117	0.000517	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000116	0.000513	CcSEcCtD
Bezafibrate—Insomnia—Topiramate—epilepsy syndrome	0.000115	0.00051	CcSEcCtD
Bezafibrate—Rash—Valproic Acid—epilepsy syndrome	0.000115	0.000509	CcSEcCtD
Bezafibrate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000115	0.000509	CcSEcCtD
Bezafibrate—Headache—Valproic Acid—epilepsy syndrome	0.000114	0.000506	CcSEcCtD
Bezafibrate—Diarrhoea—Pregabalin—epilepsy syndrome	0.000113	0.0005	CcSEcCtD
Bezafibrate—Dyspepsia—Topiramate—epilepsy syndrome	0.000112	0.000496	CcSEcCtD
Bezafibrate—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000112	0.000493	CcSEcCtD
Bezafibrate—Dizziness—Pregabalin—epilepsy syndrome	0.000109	0.000483	CcSEcCtD
Bezafibrate—Constipation—Topiramate—epilepsy syndrome	0.000109	0.000482	CcSEcCtD
Bezafibrate—Pain—Topiramate—epilepsy syndrome	0.000109	0.000482	CcSEcCtD
Bezafibrate—Nausea—Valproic Acid—epilepsy syndrome	0.000109	0.00048	CcSEcCtD
Bezafibrate—Pruritus—Gabapentin—epilepsy syndrome	0.000107	0.000474	CcSEcCtD
Bezafibrate—Indomethacin—CYP2C19—epilepsy syndrome	0.000105	0.0126	CrCbGaD
Bezafibrate—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000104	0.000461	CcSEcCtD
Bezafibrate—Rash—Pregabalin—epilepsy syndrome	0.000104	0.00046	CcSEcCtD
Bezafibrate—Dermatitis—Pregabalin—epilepsy syndrome	0.000104	0.00046	CcSEcCtD
Bezafibrate—Diarrhoea—Gabapentin—epilepsy syndrome	0.000104	0.000458	CcSEcCtD
Bezafibrate—Headache—Pregabalin—epilepsy syndrome	0.000103	0.000457	CcSEcCtD
Bezafibrate—Urticaria—Topiramate—epilepsy syndrome	0.000101	0.000448	CcSEcCtD
Bezafibrate—Abdominal pain—Topiramate—epilepsy syndrome	0.000101	0.000445	CcSEcCtD
Bezafibrate—Dizziness—Gabapentin—epilepsy syndrome	0.0001	0.000443	CcSEcCtD
Bezafibrate—Nausea—Pregabalin—epilepsy syndrome	9.81e-05	0.000434	CcSEcCtD
Bezafibrate—Rash—Gabapentin—epilepsy syndrome	9.55e-05	0.000422	CcSEcCtD
Bezafibrate—Dermatitis—Gabapentin—epilepsy syndrome	9.54e-05	0.000422	CcSEcCtD
Bezafibrate—Headache—Gabapentin—epilepsy syndrome	9.49e-05	0.000419	CcSEcCtD
Bezafibrate—Glyburide—CYP2C19—epilepsy syndrome	9.46e-05	0.0114	CrCbGaD
Bezafibrate—Hypersensitivity—Topiramate—epilepsy syndrome	9.39e-05	0.000415	CcSEcCtD
Bezafibrate—Pruritus—Topiramate—epilepsy syndrome	9.01e-05	0.000399	CcSEcCtD
Bezafibrate—Nausea—Gabapentin—epilepsy syndrome	9e-05	0.000398	CcSEcCtD
Bezafibrate—Diarrhoea—Topiramate—epilepsy syndrome	8.72e-05	0.000385	CcSEcCtD
Bezafibrate—Dizziness—Topiramate—epilepsy syndrome	8.43e-05	0.000373	CcSEcCtD
Bezafibrate—Rash—Topiramate—epilepsy syndrome	8.03e-05	0.000355	CcSEcCtD
Bezafibrate—Dermatitis—Topiramate—epilepsy syndrome	8.03e-05	0.000355	CcSEcCtD
Bezafibrate—Headache—Topiramate—epilepsy syndrome	7.98e-05	0.000353	CcSEcCtD
Bezafibrate—Nausea—Topiramate—epilepsy syndrome	7.57e-05	0.000335	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—epilepsy syndrome	6.52e-05	0.00784	CrCbGaD
Bezafibrate—Aminohippurate—ABCB1—epilepsy syndrome	6.04e-05	0.00727	CrCbGaD
Bezafibrate—Indomethacin—ALB—epilepsy syndrome	5.81e-05	0.00699	CrCbGaD
Bezafibrate—Indomethacin—ABCB1—epilepsy syndrome	5.55e-05	0.00667	CrCbGaD
Bezafibrate—Glyburide—ALB—epilepsy syndrome	5.25e-05	0.00631	CrCbGaD
Bezafibrate—Glyburide—ABCB1—epilepsy syndrome	5.01e-05	0.00602	CrCbGaD
Bezafibrate—CYP2C8—Metabolism—PFKL—epilepsy syndrome	2.06e-05	0.000154	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NEU1—epilepsy syndrome	2.05e-05	0.000154	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ATIC—epilepsy syndrome	2.05e-05	0.000154	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—UPB1—epilepsy syndrome	2.05e-05	0.000154	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—JUNB—epilepsy syndrome	2.05e-05	0.000153	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NR3C1—epilepsy syndrome	2.04e-05	0.000153	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCG2—epilepsy syndrome	2.03e-05	0.000152	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—HMOX1—epilepsy syndrome	2.01e-05	0.000151	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.01e-05	0.000151	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2e-05	0.00015	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CAT—epilepsy syndrome	1.99e-05	0.000149	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP2C19—epilepsy syndrome	1.98e-05	0.000148	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HSD17B4—epilepsy syndrome	1.97e-05	0.000148	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—SRC—epilepsy syndrome	1.97e-05	0.000147	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP11A1—epilepsy syndrome	1.97e-05	0.000147	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—KCNJ11—epilepsy syndrome	1.96e-05	0.000147	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CHRM3—epilepsy syndrome	1.96e-05	0.000147	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.95e-05	0.000146	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ABCB1—epilepsy syndrome	1.93e-05	0.000145	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—FGF2—epilepsy syndrome	1.93e-05	0.000145	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.92e-05	0.000144	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—epilepsy syndrome	1.92e-05	0.000144	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GBE1—epilepsy syndrome	1.91e-05	0.000143	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPP1R3C—epilepsy syndrome	1.91e-05	0.000143	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AGT—epilepsy syndrome	1.89e-05	0.000142	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ATIC—epilepsy syndrome	1.88e-05	0.000141	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—UPB1—epilepsy syndrome	1.88e-05	0.000141	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NEU1—epilepsy syndrome	1.88e-05	0.000141	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.86e-05	0.00014	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—APOE—epilepsy syndrome	1.85e-05	0.000139	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—HMOX1—epilepsy syndrome	1.84e-05	0.000138	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.83e-05	0.000137	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CAT—epilepsy syndrome	1.82e-05	0.000136	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	1.81e-05	0.000136	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GPX1—epilepsy syndrome	1.8e-05	0.000135	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—RELA—epilepsy syndrome	1.79e-05	0.000134	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ASAH1—epilepsy syndrome	1.79e-05	0.000134	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.79e-05	0.000134	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.78e-05	0.000133	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP2D6—epilepsy syndrome	1.77e-05	0.000133	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ABCB1—epilepsy syndrome	1.77e-05	0.000132	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GBE1—epilepsy syndrome	1.75e-05	0.000131	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	1.75e-05	0.000131	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—STXBP1—epilepsy syndrome	1.74e-05	0.000131	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.71e-05	0.000128	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NT5E—epilepsy syndrome	1.7e-05	0.000127	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALAD—epilepsy syndrome	1.7e-05	0.000127	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ADRA2A—epilepsy syndrome	1.69e-05	0.000127	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—BCHE—epilepsy syndrome	1.68e-05	0.000126	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SIRT1—epilepsy syndrome	1.65e-05	0.000124	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	1.64e-05	0.000123	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GPX1—epilepsy syndrome	1.64e-05	0.000123	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—epilepsy syndrome	1.64e-05	0.000123	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—VDR—epilepsy syndrome	1.63e-05	0.000122	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CACNA1A—epilepsy syndrome	1.62e-05	0.000122	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDH7A1—epilepsy syndrome	1.62e-05	0.000122	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC2A1—epilepsy syndrome	1.6e-05	0.00012	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	1.6e-05	0.00012	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCG2—epilepsy syndrome	1.6e-05	0.00012	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—POMC—epilepsy syndrome	1.59e-05	0.000119	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PLCB1—epilepsy syndrome	1.59e-05	0.000119	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ST3GAL3—epilepsy syndrome	1.59e-05	0.000119	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TH—epilepsy syndrome	1.58e-05	0.000118	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AGT—epilepsy syndrome	1.58e-05	0.000118	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALAD—epilepsy syndrome	1.56e-05	0.000117	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NT5E—epilepsy syndrome	1.56e-05	0.000117	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP2C19—epilepsy syndrome	1.56e-05	0.000117	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.56e-05	0.000117	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ADSL—epilepsy syndrome	1.55e-05	0.000116	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP11A1—epilepsy syndrome	1.55e-05	0.000116	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—APOE—epilepsy syndrome	1.54e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—H2AFX—epilepsy syndrome	1.54e-05	0.000115	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.54e-05	0.000115	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—epilepsy syndrome	1.53e-05	0.000115	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GLUL—epilepsy syndrome	1.52e-05	0.000114	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CACNA1D—epilepsy syndrome	1.5e-05	0.000112	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—YWHAZ—epilepsy syndrome	1.49e-05	0.000111	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	1.49e-05	0.000111	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	1.49e-05	0.000111	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NR3C1—epilepsy syndrome	1.46e-05	0.00011	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.46e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.46e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.46e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.46e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.46e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.46e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	1.45e-05	0.000109	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ALB—epilepsy syndrome	1.45e-05	0.000109	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AGT—epilepsy syndrome	1.44e-05	0.000108	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ADSL—epilepsy syndrome	1.43e-05	0.000107	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—APOE—epilepsy syndrome	1.41e-05	0.000106	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—SRC—epilepsy syndrome	1.41e-05	0.000106	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.4e-05	0.000105	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TXNRD1—epilepsy syndrome	1.4e-05	0.000105	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GLUL—epilepsy syndrome	1.4e-05	0.000105	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	1.4e-05	0.000105	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—epilepsy syndrome	1.37e-05	0.000103	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	1.37e-05	0.000103	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AQP1—epilepsy syndrome	1.36e-05	0.000102	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.33e-05	9.98e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.33e-05	9.98e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.33e-05	9.98e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.33e-05	9.98e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.33e-05	9.98e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	1.33e-05	9.97e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—POMC—epilepsy syndrome	1.33e-05	9.94e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	1.32e-05	9.92e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—HMOX1—epilepsy syndrome	1.32e-05	9.89e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.3e-05	9.78e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CAT—epilepsy syndrome	1.3e-05	9.76e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	1.28e-05	9.62e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—epilepsy syndrome	1.27e-05	9.51e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCB1—epilepsy syndrome	1.27e-05	9.49e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	1.26e-05	9.47e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	1.25e-05	9.36e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AQP1—epilepsy syndrome	1.25e-05	9.33e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TH—epilepsy syndrome	1.24e-05	9.33e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.24e-05	9.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.24e-05	9.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.23e-05	9.25e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	1.23e-05	9.21e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	1.23e-05	9.21e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.23e-05	9.19e-05	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—epilepsy syndrome	1.22e-05	9.16e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—POMC—epilepsy syndrome	1.21e-05	9.09e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—epilepsy syndrome	1.21e-05	9.06e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.2e-05	8.97e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GPX1—epilepsy syndrome	1.18e-05	8.82e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—epilepsy syndrome	1.18e-05	8.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.16e-05	8.72e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.14e-05	8.58e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	1.13e-05	8.44e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	1.13e-05	8.44e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.12e-05	8.4e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—epilepsy syndrome	1.11e-05	8.29e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.1e-05	8.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.1e-05	8.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.1e-05	8.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.1e-05	8.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.1e-05	8.27e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—epilepsy syndrome	1.06e-05	7.93e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.05e-05	7.86e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	1.04e-05	7.79e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AGT—epilepsy syndrome	1.03e-05	7.74e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.03e-05	7.7e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CAT—epilepsy syndrome	1.03e-05	7.68e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOE—epilepsy syndrome	1.01e-05	7.58e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.01e-05	7.56e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.01e-05	7.56e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.01e-05	7.56e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	1e-05	7.51e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	9.97e-06	7.47e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	9.76e-06	7.32e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.72e-06	7.28e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	9.7e-06	7.27e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—epilepsy syndrome	9.67e-06	7.25e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.63e-06	7.22e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GBE1—epilepsy syndrome	9.38e-06	7.03e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	9.38e-06	7.03e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	9.27e-06	6.95e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	9.18e-06	6.88e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	8.95e-06	6.71e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	8.89e-06	6.67e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.83e-06	6.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.82e-06	6.61e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.78e-06	6.58e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—epilepsy syndrome	8.76e-06	6.56e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	8.75e-06	6.56e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—POMC—epilepsy syndrome	8.69e-06	6.51e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	8.58e-06	6.43e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NT5E—epilepsy syndrome	8.36e-06	6.27e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALAD—epilepsy syndrome	8.36e-06	6.27e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	8.33e-06	6.25e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—BCHE—epilepsy syndrome	8.3e-06	6.22e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—epilepsy syndrome	8.21e-06	6.15e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AGT—epilepsy syndrome	8.13e-06	6.09e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.05e-06	6.03e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	8.03e-06	6.02e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.98e-06	5.98e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.98e-06	5.98e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOE—epilepsy syndrome	7.97e-06	5.97e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—epilepsy syndrome	7.92e-06	5.94e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	7.92e-06	5.93e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	7.83e-06	5.87e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.81e-06	5.85e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TH—epilepsy syndrome	7.8e-06	5.85e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.68e-06	5.76e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.65e-06	5.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	7.64e-06	5.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—BCHE—epilepsy syndrome	7.61e-06	5.7e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GLUL—epilepsy syndrome	7.5e-06	5.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	7.36e-06	5.52e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	7.26e-06	5.44e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	7.18e-06	5.38e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TH—epilepsy syndrome	7.15e-06	5.36e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.04e-06	5.28e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—epilepsy syndrome	6.93e-06	5.19e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.89e-06	5.16e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—POMC—epilepsy syndrome	6.84e-06	5.13e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.69e-06	5.01e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	6.51e-06	4.88e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CAT—epilepsy syndrome	6.43e-06	4.82e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—epilepsy syndrome	6.38e-06	4.78e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—epilepsy syndrome	6.25e-06	4.69e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	6.25e-06	4.68e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—epilepsy syndrome	6.24e-06	4.68e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.05e-06	4.53e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.05e-06	4.53e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	5.97e-06	4.47e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CAT—epilepsy syndrome	5.89e-06	4.42e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPX1—epilepsy syndrome	5.81e-06	4.36e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	5.73e-06	4.29e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	5.46e-06	4.09e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPX1—epilepsy syndrome	5.33e-06	3.99e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—epilepsy syndrome	5.32e-06	3.98e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AGT—epilepsy syndrome	5.1e-06	3.82e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOE—epilepsy syndrome	4.99e-06	3.74e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.93e-06	3.69e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—epilepsy syndrome	4.86e-06	3.64e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.8e-06	3.6e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.77e-06	3.58e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AGT—epilepsy syndrome	4.67e-06	3.5e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOE—epilepsy syndrome	4.58e-06	3.43e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—epilepsy syndrome	4.48e-06	3.36e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.31e-06	3.23e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—POMC—epilepsy syndrome	4.29e-06	3.21e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.1e-06	3.07e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.08e-06	3.06e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—POMC—epilepsy syndrome	3.93e-06	2.95e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—epilepsy syndrome	3.91e-06	2.93e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.9e-06	2.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.85e-06	2.89e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TH—epilepsy syndrome	3.84e-06	2.88e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—epilepsy syndrome	3.59e-06	2.69e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—epilepsy syndrome	3.48e-06	2.61e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	3.42e-06	2.56e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.2e-06	2.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.16e-06	2.37e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	3.14e-06	2.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.08e-06	2.31e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.86e-06	2.14e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	2.74e-06	2.06e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.51e-06	1.88e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.46e-06	1.84e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.11e-06	1.58e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.92e-06	1.44e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—epilepsy syndrome	1.72e-06	1.29e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.68e-06	1.26e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.58e-06	1.18e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—epilepsy syndrome	8.46e-07	6.34e-06	CbGpPWpGaD
